GILEAD SCIENCES INC (1GILD.MI) Stock Price & Overview
BIT:1GILD • US3755581036
The current stock price of 1GILD.MI is 126.1 EUR. Today 1GILD.MI is up by 4.44%. In the past month the price increased by 25.29%.
1GILD.MI Key Statistics
- Market Cap
- 156.45B
- P/E
- 18.36
- Fwd P/E
- 16.77
- EPS (TTM)
- 6.87
- Dividend Yield
- 2.16%
1GILD.MI Stock Performance
1GILD.MI Stock Chart
1GILD.MI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to 1GILD.MI.
1GILD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1GILD.MI. 1GILD.MI scores excellent on profitability, but there are some minor concerns on its financial health.
1GILD.MI Earnings
On February 10, 2026 1GILD.MI reported an EPS of 1.86 and a revenue of 7.92B. The company beat EPS expectations (0.73% surprise) and beat revenue expectations (0.98% surprise).
1GILD.MI Forecast & Estimates
37 analysts have analysed 1GILD.MI and the average price target is 118.53 EUR. This implies a price decrease of -6.01% is expected in the next year compared to the current price of 126.1.
For the next year, analysts expect an EPS growth of 9.44% and a revenue growth 3.45% for 1GILD.MI
1GILD.MI Groups
Sector & Classification
1GILD.MI Financial Highlights
Over the last trailing twelve months 1GILD.MI reported a non-GAAP Earnings per Share(EPS) of 6.87. The EPS increased by 76.79% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.88% | ||
| ROA | 13.86% | ||
| ROE | 37.8% | ||
| Debt/Equity | 0 |
1GILD.MI Ownership
1GILD.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 24.27 | 38.751B | ||
| ARGX | ARGENX SE | 24.07 | 38.739B | ||
| 22UA | BIONTECH SE-ADR | N/A | 20.871B | ||
| ABVX | ABIVAX SA | N/A | 7.836B | ||
| 2X1 | ABIVAX SA | N/A | 7.812B | ||
| GXE | GALAPAGOS NV | N/A | 1.904B | ||
| GLPG | GALAPAGOS NV | N/A | 1.899B | ||
| NANO | NANOBIOTIX | N/A | 1.396B | ||
| 6IV | INVENTIVA SA | N/A | 1.174B | ||
| IVA | INVENTIVA SA | N/A | 1.096B | ||
| PHIL | PHILOGEN SPA | 16.81 | 614.04M | ||
| GNFT | GENFIT | N/A | 437.275M | ||
| AYJ | VALNEVA SE | N/A | 417.758M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1GILD.MI
Company Profile
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. The company also develops the HB-400 program and the HB-500 program. The company develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. The company has a cancer program, namely TREX1. The company operates in more than 35 countries worldwide.
Company Info
GILEAD SCIENCES INC
333 Lakeside Dr
Foster City CALIFORNIA US
Employees: 17600
Phone: 13026587581
GILEAD SCIENCES INC / 1GILD.MI FAQ
What does GILEAD SCIENCES INC do?
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The company is headquartered in Foster City, California and currently employs 17,600 full-time employees. The company is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. The company is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. The company also develops the HB-400 program and the HB-500 program. The company develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. The company has a cancer program, namely TREX1. The company operates in more than 35 countries worldwide.
What is the current price of 1GILD stock?
The current stock price of 1GILD.MI is 126.1 EUR. The price increased by 4.44% in the last trading session.
What is the dividend status of GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) has a dividend yield of 2.16%. The yearly dividend amount is currently 2.65.
What is the ChartMill rating of GILEAD SCIENCES INC stock?
1GILD.MI has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the sector and industry classification for GILEAD SCIENCES INC?
GILEAD SCIENCES INC (1GILD.MI) operates in the Health Care sector and the Biotechnology industry.
What is the employee count for 1GILD stock?
GILEAD SCIENCES INC (1GILD.MI) currently has 17600 employees.
What is GILEAD SCIENCES INC worth?
GILEAD SCIENCES INC (1GILD.MI) has a market capitalization of 156.45B EUR. This makes 1GILD.MI a Large Cap stock.